STEPHANIE BARTLETT: Open Payments
NPI 1508629726 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 40 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $995 · 2025 $776
Food & beverage: $776
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $205 |
| AstraZeneca Pharmaceuticals LP | 9 | $169 |
| Novo Nordisk Inc | 4 | $86 |
| Phathom Pharmaceuticals, Inc. | 3 | $52 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Lilly USA, LLC | 3 | $50 |
| Ardelyx, Inc. | 1 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Edwards Lifesciences Corporation | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $24 |
Products named: AIRSUPRA, VRAYLAR, Ozempic, VOQUEZNA, TRELEGY ELLIPTA, UBRELVY, FARXIGA, IBSRELA.
Industry payments across AZ — which companies pay providers there.
